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Abstract
Background: The response of macrophages to danger signals is an important early stage in the
immune response. Our understanding of this complex event has been furthered by microarray
analysis, which allows the simultaneous investigation of the expression of large numbers of genes.
However, the microarray resources available to study these events in livestock animals are limited.
Results: Here we report the development of a bovine macrophage specific (BoMP) cDNA
microarray. The BoMP microarray contains 5026 sequence elements (printed in duplicate) and
numerous controls. The majority of the clones incorporated on the microarray were derived from
the BoMP cDNA library generated from bovine myeloid cells subjected to various stimuli, including
over 900 sequences unique to the library. Additional clones representing immunologically
important genes have been included on the BoMP microarray. The microarray was validated by
investigating the response of bovine monocytes to stimulation with interferon-γ and
lipopolysaccharide using amplified RNA. At 2 and 16 hours post stimulation 695 genes exhibited
statistically significant differential expression, including; 26 sequences unique to the BoMP library,
interleukin 6, prion protein and toll-like receptor 4.
Conclusion: A 5 K cDNA microarray has been successfully developed to investigate gene
expression in bovine myeloid cells. The BoMP microarray is available from the ARK-Genomics
Centre for Functional Genomics in Farm Animals, UK.
Background
Macrophages (mφ) play a key role in the immune system,
acting as a bridge between the innate and adaptive
immune responses. Mφ are sentinel cells that instigate the
removal of invading pathogens, either by phagocytosis or
by signalling to other components of the immune system.
These signals include the release of various cytokines and
the ability of mφ to act as antigen-presenting cells.
Mφ become activated when they interact with conserved,
pathogen-specific stimuli, e.g. pathogen associated molec-
ular patterns (PAMPs) such as lipopolysaccharide (LPS)
and double-stranded RNA, characteristic of gram-negative
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bacterial or viral infections respectively. In addition
cytokines, e.g. interferon-γ (IFN-γ) produced by T lym-
phocytes and other immune cells, activate mφ. Activation
results in extensive remodelling of the mφ transcriptome,
leading to morphological and physiological changes in
the cell, including; alterations in shape, mobility and cell
surface marker expression. These modifications equip the
mφ to deal effectively with the invading threat. However,
many pathogens have evolved the ability to circumvent
the action of mφ and several have developed the ability to
exist undetected within the mφ. These include a number
of protozoan parasites including Leishmania species, Toxo-
plasma gondii and Theileria annulata [1,2].
The complexity of the mφ response to activation and
infection is ideally suited for analysis by microarray tech-
nology, which allows the expression of thousands of
genes to be investigated simultaneously. Numerous
microarray experiments have now been published on the
response of human and murine mφ to a range of stimuli,
including; various pathogens, PAMPs and cytokines
[reviewed in [3]]. In contrast, only a handful of experi-
ments have been reported for livestock species. For exam-
ple, five publications have investigated the response of
bovine mφ and monocytes to stimuli [4-8]. Three of these
studies have involved the use of commercially available
human arrays. The most recent study used an in house
bovine cDNA microarray [8], whilst the fifth study used a
commercially available bovine array, which contains a
limited number of immunologically important genes [6].
This partly results from an under-representation of
immune genes in the EST datasets, caused by the genera-
tion of cDNA libraries from unactivated or uninfected
immune tissue [9]. Although there are over 490,000 pub-
lished bovine ESTs, IFN-γ and interleukin-2 (IL2) are only
represented by one and two bovine ESTs respectively,
whilst no bovine ESTs have been published that represent
IL4. This problem is not restricted to livestock species,
Wells and co-authors [10] have shown that mφ transcripts
are poorly represented within the RIKEN mouse EST set,
one of the most extensive collections of mouse transcripts
currently available [11,12]. Eighteen percent of clones
from a murine mφ cDNA library were novel, failing to
match any published sequences [10]. Similarly, we have
recently reported the construction of a bovine mφ (BoMP)
specific cDNA library, in which over a third of clones
appear to be novel, although this figure is decreasing as
more bovine sequences become available [13]. The high
percentage of novel sequences results from the inclusion
of RNA samples in the library template that were collected
from myeloid cells subjected to a range of different stimuli
to maximize the number of transcripts associated with the
immune response.
Here we report the use of BoMP library clones to construct
a 5 K bovine macrophage specific (BoMP) cDNA microar-
ray, which contains a large number of unique sequences.
We also report the proof-of-principle experiment carried
out using the BoMP microarray to investigate the response
of bovine peripheral monocytes to LPS and IFN-γ stimula-
tion, which stimulate cellular pathways of importance in
the in vivo inflammatory and infectious response of mye-
loid cells.
Results
Characterization of the BoMP microarray
In total the BoMP microarray comprises 5026 clones
printed in duplicate and numerous controls. Over 52% of
clones match annotated gene sequences, a further 28%
match ESTs and the remaining clones are currently unique
to the BoMP library (Table 1 & Additional file 1). The
majority of the clones were selected from the previously
described BoMP cDNA library [13]. Approximately
10,000 clones from this library were considered for inclu-
sion on the BoMP microarray. Clones that matched pub-
lished sequences with E values less than e-20 were included
on the microarray, including those that only matched EST
sequences (3599 clones). In addition, a representative
clone from each cluster of sequences unique to the BoMP
library was included on the microarray (220 clones). The
remaining sequences were analysed using ESTScan
[14,15], a web-based program that detects coding
sequence by taking into account sequencing errors that
frequently occur in single-pass sequences and can cause
frame-shift mutations (174 clones). A further 592 unique
BoMP clones were also randomly chosen for inclusion on
the microarray.
T. annulata infected material was used to generate the
BoMP library and as a result parasite sequence containing
clones represent approximately 5% of the library [13].
Similarly, the infectious T. annulata sporozoites were pre-
pared by homogenizing whole infected ticks, which has
Table 1: Composition of the BoMP cDNA microarray.
BoMP cDNA library clones
BLASTN hits 2185 (43.5%)
EST hits – bovine 1139 (22.7%)
human 156 (3.1%)
other 119 (2.4%)
Unique clusters 220 (4.4%)
ESTscans 174 (3.5%)
Unique singletons 592 (11.8%)
Additional clones
MARC1-4/BARC5 355 (7.1%)
Other libraries 26 (0.5%)
Amplicons 60 (1.2%)
Total 5026
The percentage of clones included on the BoMP microarray from 
various sources is listed along with the annotation available for the 
BoMP library clones.
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resulted in the presence of tick sequence containing clones
in the library [13]. Eight clones known to contain non-
bovine sequences have been included on the microarray;
including C0006007g13 [EMBL: AJ817072] and
C0006019k23 [EMBL: AJ820886], which match tick and
parasite sequences respectively. These clones have been
included as additional controls for a T. annulata infection
experiment which will be reported elsewhere (Jensen et
al., in prep.).
A number of immunologically important genes have not
been detected in the BoMP library to date, partly because
it has not been mined deeply. Therefore, a list of over 400
genes desirable for inclusion on the array was compiled.
Where possible representative clones for these genes were
selected for inclusion on the microarray from the various
libraries housed at the ARK-Genomics facility (381
clones). The majority of these clones came from the Meat
Animal Research Centre (MARC) and Beltsville Agricul-
tural Research Centre (BARC) libraries MARC 1–4 BOV
and BARC 5 BOV [16,17], e.g. macrophage migration
inhibition factor (MIF) and integrin beta 6. Clones were
not available for 60 genes on our compiled list. Therefore
we generated amplicons for each of these clones using
publicly available sequence information to design oligo-
nucleotides suitable for amplification, e.g. IL6, caspase 3
(CASP3) and Toll-like receptor 9 (TLR9) (Table 2).
The BoMP microarray has been constructed at the ARK-
Genomics Centre for Functional Genomics in Farm Ani-
mals [18] and submitted to ArrayExpress as ARK-Genom-
ics Bovine Macrophage Specific-BoMP-cDNA microarray
5K v1.0 and has the accession number A-MEXP-495
[19,20].
Analysis of microarray quality
Five randomly selected microarray slides from the print
run were hybridized with Panomer 9 oligonucleotides
(Molecular Probes). This hybridization visualized the size
and shape of all printed spots, which allowed us to ensure
uniformity in the amount of DNA spotted by each pin and
to check the integrity of each spot. This test hybridization
confirmed that the microarray printing had been success-
ful (data not shown).
Normalized data from the experiment described below
was used to investigate the consistency of the intensity
measurements for replicate spots. The contributions of
slide, gene, replicate spots and channel to the variability
of the logarithm of the intensities were assessed by fitting
them as random effects in a linear model. The fixed effects
of animal and time were also included in the model.
Intensity differences between genes were the largest con-
tributor, accounting for 79% of the variation (Table 3, var-
iance %). Almost all the remaining variation was
accounted for equally between replicate spots and
between channels, leaving little contribution from slides.
Therefore, approximately 80% of the overall measured
variation was of biological rather than technical origin.
This summary is an oversimplification, which is illus-
trated by the variation observed in values when the time
points are examined separately (Table 3, last 6 columns)
and results from the failure to allow for the effects of dif-
ferentially expressed genes in the 2 and 16 hour samples.
The results for the 0 hour samples would be expected to
be similar to that from a self-self hybridization and they
do show more agreement that the other time points. The
correlations between channel log(intensities) for the 0, 2
and 16 hour time points were 0.95, 0.89 and 0.88 respec-
tively (calculated as (100-channel%)/100 from the last 3
columns of Table 3).
Microarray analysis of monocyte activation
As a further evaluation of the BoMP microarray, it was
used to investigate the response of bovine peripheral
monocytes to stimulation. As part of a larger experiment,
peripheral monocytes were isolated from six Holstein-
Friesians under cold conditions before stimulation with
LPS and IFN-γ. RNA was isolated from the cells of each
animal at 0, 2 and 16 hours post activation. The quantity
of total RNA (totRNA) isolated from these cells was too
low for direct use in microarray experiments and therefore
amplified RNA (aRNA) was generated.
The parameters used to identify genes exhibiting statisti-
cally significant differences in gene expression during the
time course were a 2 fold or greater change in gene expres-
sion and a false discovery rate value (FDRmax) less than
0.01. Using these criteria 713 clones exhibited statistically
significant changes in gene expression during the time
course. Several of these clones represented the same gene
and therefore a total of 695 genes exhibited differential
expression (Additional file 2). Twenty-six of these were
sequences unique to the BoMP library [13]. These
included C0006011i04 [EMBL: AJ818203] that was up-
regulated 8.4 fold by 16 hours post activation and
C0005209g19 [EMBL: AJ816691] that was down-regu-
lated 13.2 fold by 16 hours post activation. A further 171
sequences that exhibit differential expression currently
only match ESTs. Putative gene names have been assigned
to the remaining 498 sequences. The gene ontology infor-
mation that is available for 398 of these genes illustrates
the broad range of biological processes affected by activa-
tion with LPS and IFN-γ, including; signal transduction,
transcription, immune response, apoptosis, cell prolifera-
tion, metabolism, intracellular transport, translation and
proteolysis. Furthermore, 190 of the genes have been
incorporated into KEGG pathways, with the largest
number of genes being involved in cytokine-cytokine
receptor interactions, haematopoietic cell lineage, TLR sig-
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Table 2: Amplicons generated to represent 60 immunologically important genes.
Gene Symbol Accession No. Size (bp) Forward Primer 5'-3' sequence Reverse Primer 5'-3' sequence
Annexin-A5 ANXA5 CO883855 700 ATG GCA CAG GTT CTC AGA GG CCA AAT TGC CAG AAG TCT CC
Baculoviral IAP-repeat containing 5 BIRC5 BE486047 451 CCT GGC AGC TCT ACC TCA AG CCC TGG AAA CGA CGT GTC TG
B-cell CLL/lymphoma 3 BCL3 CK771977 537 CTT CTT GGC ACT CGG TGT TC GAC CAG AGG CAA TTT ACT ACC
Capping protein (actin filament) gelsolin like CAPG AY219899 615 TAT GGA GGG TGG AGA AGC TG TGG GAC CCA AGA CCT GTA TC
Casein kinase II α1 CSNK2A1 X54962 405 GTT AAT ACA CAC AGA CCC CGA GCT ATG GCA GTA ATC AAG GGC C
Caspase 3 CASP3 CK958902 679 GTG GAT GCA GCA AAC CTC AG CCA TTT GCT CAC TTG GCA TAC
Caspase 7 CASP7 CK436554 549 TCT TCC AAA GTC ACC ACC AG GGA GTG GCT CTT GGT TTG TG
Caspase recruitment domain family member 4 CARD4 CO886987 630 ATG TCG GAG CCA GGT ACA TC GAA GTC CCA CCT CAG CAG AC
CD2 antigen CD2 CN789613 544 CAG AAC TGT GAG CTG CAA GG TTG CTG GTG AAC TTG TGT GC
CD3 antigen γ CD3G CD445323 518 GAA GGA GTT CGC CAG TCA AG TGA TGA GAA TAG CCA ATA AGC AC
CD40 ligand CD40LG Z48469 652 TAA CGC AGC ATG ATC GAA AC AGA ACT GTG GGT GTT TGC AG
CD63 antigen CD63 AJ012589 606 TTC TCC TGC TGG TCT TCT GC GGA TCT CCA CAA AGG CAA TG
CD80 antigen CD80 BF039039 522 GGT ACT CCA ACC AGC GTC TC AGG TGT AGG TGC CAC TGT CC
CD86 antigen CD86 AJ291475 674 GCC TTC TTC AAC GAG ACT GG GCA ATC CAG AGG ATG TGG TC
CD200 receptor 1 CD200R1 CK831048 552 CTG TGG ACA GAA AGC AGA GC GGT TCT GAC ACC TTT ATC CAG
Chemokine (C motif) ligand 1 XCL1 AF354057 411 TCA GCC TCT TAC TGC ACA GC AAA TGA GGT GGC TGG CTA GG
Chemokine (C-C motif) ligand 8 CCL8 S67954 667 TGA GAC CAA CTC AGC AAT CG AGT GGA AGG ACC TCA CCA TC
Colony stimulating factor 2 CSF2 U22385 602 GAG GAT GTG GCT GCA GAA CC CCT GTA TCA GGG TCA ACA TGG
Colony stimulating factor 2 receptor α CSF2RA BE480577 455 CCA AAT GCC AGC CTA AAT GTG CGA GAG GTC TTG GAG GTG AC
Complement component 5 receptor 1 C5R1 X65861 396 ATC ATC CAG CAC AAC CAC TG GCA GGA GGA AGG TGT AAC AG
FcγRIα (CD64) FCGR1A AF162866 630 TCT GGT CAA CCT GAG CTG TG TAA GAT GCC AAG GGA GTT GC
FcγRIIIb (CD16b) FCGR3B AF132036 502 CTT TCA GCT GAC ACG CAA AC TTT CCT GCT GCT CCC AGA G
Inhibitor of kappa light polypeptide gene enhancer in 
B-cells, kinase β
IKBKB AJ414556 688 TTT GAC AAC AGC AGG GTC AC TGC AGA CCA CGG TCT TAC TG
Inhibitor of kappa light polypeptide gene enhancer in 
B-cells, kinase γ
IKBKG AJ414557 694 ATG GAG TGC ATC GAG TAG GG AGA GAG GAG CTC ACC TTG TG
Insulin-like growth factor 1 IGF1 X15726 661 GTG ATC TGA GGA GGC TGG AG AGG TGA TGG AGA AGG GAG TG
Integrin αV (CD51) ITGAV BM431105 505 CAT ATC TGC GGG ATG AAT CTG TCC ATC TCT GAT TGC TGG TG
Integrin α6 (CD49f) ITGA6 CK970520 554 TAC CCT GAT GTT GCT GTT GG ATG TTG TCG TCT CCA CAT CC
Integrin β1 (CD29) ITGB1 AF468058 691 TGT GTT TCA CTT CGC TGG AG TTC GCT GTT CAC CTC ATC TG
Integrin β3 (CD61) ITGB3 CN791459 530 TGT TCT CCA GCT CAT TGT GG TCT TGC CAA AGT CAC TGC TG
Intercellular adhesion molecule (CD50) ICAM3 L41844 628 CCA AGA GAT TGT CTG CAA CG GCC CAA GAT CGC TAA CAC TC
Interferon α IFNA Z46508 439 GGT CCT GAT GCT CCT GAG AC CCT GCA AGT TTG TTG AGG AAG
Interferon β1 IFNB1 M15477 568 TCT CCA CCA CAG CTC TTT CC TCT CAC CTC AAA GTC ACA TTG
Interferon γ IFNG M39867 561 GGA GCT ACC GAT TTC AAC TAC TCC G GCA GGC AGG AGG ACC ATT ACG
Interferon regulatory factor 2 IRF2 AJ490936 686 AAA CTG GGC CAT CCA TAC AG TGT TGG ACG TGA CAA AGG TG
Interleukin 1β IL1B M37211 699 AAG GCT CTC CAC CTC CTC TC TGG TTG CTC ATC AGA AGC TG
Interleukin 1 receptor-associated kinase 1 IRAK1 BG692698 405 CTC TCT CCT GGC CTC AGC CTT CCG CCT CCT CTT CAA C
Interleukin 2 IL2 M13204 498 GGT CGT TCA TGT CAG CAA TG GAG GCA CTT AGT GAT CAA GTC
Interleukin 4 IL4 M77120 451 GCA TTG TTA GCG TCT CCT GGT AAA C CTT CAT AAT CGT CTT TAG CCT TTC C
Interleukin 6 IL6 X57317 620 ATG AAC TCC CGC TTC ACA AGC TAC TTC ATC CGA ATA GCT CTC
Interleukin 8 IL8 AF232704 660 CAG CAG AGC TCA CAA GCA TC AAA AGC AGG ATT TCC AGA TCG
Interleukin 12A IL12A U14416 350 CAG CAA CAC GCT ACA GAA GG CCT GCA TCA GCT CAG CAA TA
Interleukin 12B IL12B U11815 553 CCT GTC ACA AAG GAG GCG AGG C CGT CAG GGA GAA GTA GGA ATG CGG
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Interleukin 13 IL13 CB454692 477 CCT CAA TTT CTT CCT GTG CTG ATG GTC AGG ATC TGC CTC TG
Interleukin 15 IL15 U42433 323 ATC CAG TGC TAC TTG TGT TTA C GCT GTT TGC TAG CAT GGT AAG
MHC class II DYA BOLA-
DYA
AJ580583 623 ACC ACT TGG AAC AGC CAC TC CAG TGC TCC ACT CTG CAG TC
Myeloid differentiation primary response gene MYD88 AJ634627 431 GTG GTG GTG GTC TCT GAC G GTG CCA CGT GTT CTA TGC AG
Nuclear factor of kappa light polypeptide gene 
enhancer in B-cells 2 (p49/p100)
NFKB2 CO259349 411 GGC TAT ACC CAG TCC ACC TG TGA GGT CAA GAG GTG TGT GG
Prostaglandin-endoperoxide synthase 2 PTGS2 AF031698 651 CCA GAG CTC TTC CTC CTG TG GCA GCT CTG GGT CAA ACT TC
Selectin P ligand (CD162) SELPLG BF654668 421 ACC ATC TTC CTC GTG TGC AC CTA CCG GAG GTT CTG TTT GC
SH3-domain kinase binding protein 1 SH3KBP1 AJ819523 340 GTC AGG GCT TGA AAG GGA AG GCC TTC TGT TCC TGC CAT AC
Signal transducer & activator or transcription 1 STAT1 BE588937 519 GCG AGT CAG ATC CAA GAT AG ATC CTG AAG GTT ACG CTT GC
Tissue inhibitor of metalloproteinase 2 TIMP2 M32303 617 GGG CCA AAG CAG TCA ATA AG TTC ATG CTG TGT CCA GGA AG
Toll-like receptor 7 TLR7 AY487802 693 GCC TTC TGA TTT CCA GCA TC TTT GTC AGG CAC CTG ATT TG
Toll-like receptor 8 TLR8 AY642125 362 GGT GAT GAA TGA GCT GCG C CTT TGC CAA AAC AAG CCC TC
Toll-like receptor 9 TLR9 AJ509825 694 TCA CCA GCC TCT CCT TAA TCT C GAG AGA ACT GTC CTT CAA CAC C
Transforming growth factor β1 TGFB1 M36271 668 GCC ATA CTG GCC CTT TAC AA GCT GAC GAA CAC AGC AGT TC
Transforming growth factor β3 TGFB3 CA034974 374 AGG TGT GGA AAT CAG CAT CC CTG AGC AGA AGT TGG CAT AG
Transforming growth factor β receptor II TGFBR2 CK772005 701 GTG TTG AGG GAG CCA TCT TC AAC CTG CAG GAG TAC CTG AC
Tumour necrosis factor α TNF AF011926 660 AGC TGG CGG AGG AGG TGC TC CAG GGC GAT GAT CCC AAA GTA GAC 
C
TNFRSF6 (fas) FAS U34794 645 TTC GGA AGA ACG GTA TGG AG CCT GTG GAT AGG CAT GTG TG
List of the genes chosen for amplicon construction. The sequences used to design the primers and the sizes of the clone inserts are listed.
Table 2: Amplicons generated to represent 60 immunologically important genes. (Continued)
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nalling, mitogen activated protein kinase (MAPK) signal-
ling, Jak-STAT signalling, apoptosis, focal adhesion,
complement and coagulation cascade, regulation of actin
cytoskeleton and calcium signalling.
The limited number of time points sampled in this exper-
iment restricts the information that can be obtained from
cluster analysis. However, the 695 genes can be separated
into groups exhibiting 8 broad expression patterns. The
genes up-regulated at 2 hours fall into 3 groups; those that
remain up-regulated (133 genes) including chemokine
(C-C motif) ligand 2 (CCL2) and prion protein, those that
return to resting levels (132 genes) including v-rel reticu-
loendotheliosis viral oncogene homolog (REL) and
finally TIMP metallopeptidase inhibitor 1 (TIMP1) that is
down-regulated beyond the resting state level. The genes
down-regulated at 2 hour post activation can be grouped
in a similar manner; those that remain down-regulated
(48 genes) including v-fos FBJ murine osteosarcoma viral
oncogene (FOS), those that return to resting levels (114
genes) including chemokine (C-C motif) receptor 2
(CCR2) and finally C0006007l14 [EMBL: AJ817952]
which is up-regulated above the resting state level. The
remaining genes exhibit a delayed alteration in expression
that was observed only at 16 hours, and were either up-
regulated (110 genes) e.g. fibronectin 1 (FN1) or down-
regulated (151 genes) e.g. CD86 antigen.
Eighteen differentially expressed genes are represented by
more than one clone. The duplicate clones of 13 of these
genes are grouped together by expression pattern, e.g. FN1
and CCR1. The duplicate clones for the remaining 5
genes, e.g. IL12A, fall into different groups. Further analy-
sis shows that the duplicate clones exhibit similar hybrid-
ization patterns, but the differential expression detected
by one clone lies outside the threshold criteria used to
identify differentially expressed genes.
2 hours post LPS & IFN-γ stimulation
A total of 444 genes exhibited differential expression in
monocytes at 2 hours post activation compared to resting
monocytes (≥ 2 fold, FDRmax ≤ 0.01). Of these 279 were
up-regulated and the top 25 genes exhibiting greatest up-
regulation are listed in Table 4. Eight of these are chemok-
ines, including IL8 and CCL2. Interestingly the prion pro-
tein was up-regulated on average 28.1 fold after 2 hours
activation. Three of the most up-regulated genes are only
represented by ESTs.
A further 165 genes are down-regulated 2 hours post acti-
vation compared to resting cells and the top 25 genes are
listed in Table 5. These include IL16, CCR2 and MAPK14.
Several of the most down-regulated genes are transcrip-
tion factors, e.g. CCCTC-binding factor (CTCF), TAF7
RNA polymerase II, TATA box binding protein-associated
factor (TAF7) and nuclear factor (erythroid-derived 2)
(NFE2).
16 hours post LPS & IFN-γ stimulation
A total of 457 genes exhibit differential expression in
monocytes at 16 hours post activation compared to rest-
ing monocytes (≥ 2 fold, FDRmax ≤ 0.01). Of these 253
are up-regulated and the top 25 genes exhibiting greatest
up-regulation are listed in Table 6. There is considerable
overlap between the top 25 genes up-regulated at 2 and 16
hours post activation, including IL8 and prion protein.
Other up-regulated genes include IL1β, IL2 receptor β
chain (IL2RB) and actinin α1.
A further 204 genes are down-regulated at 16 hours post
activation and the top 25 genes are listed in Table 7. These
include the previously mentioned unique sequence
C0005209g19 [EMBL: AJ816691] and five sequences that
only match ESTs. Two ribonucleases are down-regulated,
as well as cell surface receptors; IL6 receptor (IL6R), man-
nose receptor, C type 1-like 1 (MRC1L1) and CD59. Only
2 genes are found in the top 25 down-regulated genes at 2
and 16 hours post activation; IL16 and chromosome 6
open reading frame 32 (C6orf32) protein.
Validation of microarray results
To validate the results from the microarray experiment,
thirty genes were chosen for reverse transcription-
polymerase chain reaction (RT-PCR) analysis. The mRNA
levels of all thirty appeared to follow the same pattern as
seen on the microarray (data not shown). The correct
identification of the representative clones for these 30
genes was confirmed by sequence analysis (data not
Table 3: Factors affecting intensity measurements.
Effect Variance SE (variance) Variance % Variance 0
hours
Variance 2
hours
Variance 16
hours
Variance 0
hours (%)
Variance 2
hours (%)
Variance 16
hours (%)
Slide 0.032 0.015 2 0.035 0.161 0.054 2 10 4
Gene 1.146 0.006 79 1.126 1.152 1.160 80 71 77
Replicate Spots 0.135 0.001 9 0.174 0.123 0.107 12 8 7
Channel 0.145 0.001 10 0.069 0.179 0.186 5 11 12
The contributions to variation in log(intensity) of slide, gene, replicate spots and channel, together with their standard errors and percentage 
variance accounted for. Equivalent estimates and percentages are presented separately for the 3 time points
BMC Genomics 2006, 7:224 http://www.biomedcentral.com/1471-2164/7/224
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shown). Ten of these genes were selected for further quan-
titative RT-PCR (qRT-PCR) analysis to verify the abun-
dance of mRNA present in the original totRNA samples
from the six Holstein-Friesians used to generate the aRNA
for the microarray experiment (Table 8). These genes were
chosen because they displayed a range of differential
expression during the time course. CCL2, prion protein
and IL6 were highly up-regulated during the experiment,
whilst FOS was down-regulated. FN1, CCR1 and comple-
ment component 1, r subcomponent (C1R) were up-reg-
ulated by 16 hours post activation, whilst CD86 was
down-regulated by this time-point. CD9 and CD44 did
not differ significantly during the time course.
The correspondence between the qRT-PCR and microar-
ray expression measurements is shown in Figure 1. There
is good agreement between the average log(fold changes)
for the 10 genes, with an overall correlation of 0.78 (Fig-
ure 1A). The means for 6 genes; C1R, CCR1, CD86, FN1,
FOS & PRNP, lie close to the line of equality. CD9 and
CD44 exhibit 2–3 times higher fold changes by qRT-PCR
than by microarray analysis and CCL2 results are 5 and 13
times greater. The fold change was dramatically different
for IL6, being 70 and 130 times greater by qRT-PCR anal-
ysis than microarray analysis. The correlation between the
qRT-PCR and microarray data was further investigated by
comparing the results for individual animals. The individ-
Table 4: The top 25 genes exhibiting increased mRNA abundance 2 hours post activation.
Clone E value Accession No. Gene Symbol Gene Fold Increase FDRmax P value
pIL8 0.0 NM_173925 IL8 Interleukin 8 40.00 1.23E-18 4.91E-22
MARC_3BOV_60P17 0.0 NM_174299 CXCL2 Chemokine (C-X-C motif) ligand 2 
(GROβ/MIP2A)
38.20 1.25E-15 1.24E-18
C0006019e20 0.0 NM_181015 PRNP Prion protein 28.13 1.05E-20 2.08E-24
MARC_1BOV_101M3 0.0 NM_174263 CCL20 Chemokine (C-C motif) ligand 20 
(MIP3A)
25.81 3.14E-10 3.56E-12
MARC_1BOV_94L3 0.0 NM_174300 CXCL6 Chemokine (C-X-C motif) ligand 6 22.91 1.72E-11 1.23E-13
C0005209b8 6.00E-72 XM_612426 CCRN4L CCR4 carbon catabolite repression 
4-like
20.49 1.64E-11 1.14E-13
C0006018n14 0.0 NM_174006 CCL2 Chemokine (C-C motif) ligand 2 
(MCP-1)
19.45 1.32E-07 4.19E-09
C0005204j16 0.0 XM_864683 CXCL3 Chemokine (C-X-C motif) ligand 3 
(GROγ/MIP2b)
18.16 1.20E-13 3.40E-16
C0006020d11 0.0 XM_865242 ZFAND2A Zinc finger, AN1-type domain 2A 17.61 1.10E-14 1.31E-17
C0006011e13 e-179 CK976904 - EST 16.71 3.10E-08 8.41E-10
C0005208k22 e-167 NM_173198 NR4A3 Nuclear receptor subfamily 4, group 
A, member 3
15.65 2.39E-12 1.14E-14
C0006020e20 0.0 CB419326 - EST 14.07 9.10E-12 5.60E-14
MARC_3BOV_36F6 0.0 NM_175827 CCL5 Chemokine (C-C motif) ligand 5 
(RANTES)
13.84 2.90E-12 1.47E-14
C0006018g13 0.0 XM_611249 SLCO4A1 Solute carrier organic anion 
transporter family, member 4A1
13.79 4.62E-10 5.89E-12
MARC_1BOV_72M12 0.0 XM_866821 CXCL10 Chemokine (C-X-C motif) ligand 10 
(IP10)
13.71 1.09E-05 6.09E-07
C0005199c13 0.0 AY248754 TNFAIP3 TNF-alpha induced protein 3 13.48 2.34E-08 5.90E-10
C0006015e11 0.0 XM_881561 PMAIP1 Phorbol-12-myristate-13-acetate-
induced protein 1
12.99 1.95E-12 8.90E-15
C0005202i8 0.0 XM_583725 APOBEC3A Apolipoprotein B mRNA editing 
enzyme, catalytic polypeptide-like 3A
12.96 1.20E-13 2.97E-16
MARC_3BOV_120N21 0.0 NM_174028 CSF3 Colony stimulating factor 3 
(granulocyte) (G-CSF)
12.76 8.11E-11 7.73E-13
C0006015n15 2.00E-69 NM_002748 MAPK6 Mitogen-activated protein kinase 6 
(erk-3)
12.64 8.88E-12 5.11E-14
C0006016h15 0.0 XM_613370 RGS1 Regulator of G-protein signalling 1 12.59 5.10E-09 1.00E-10
C0006013p15 e-158 CB534198 - EST 12.59 1.93E-11 1.50E-13
C0005202d9 0.0 XM_870158 ANKRD22 Ankyrin repeat domain 22 11.99 6.36E-17 3.79E-20
MARC_1BOV_57B12 0.0 NM_174348 ICAM1 Intercellular adhesion molecule 1 
(CD54)
11.40 6.40E-10 9.15E-12
C0005206b23 3.00E-82 NM_001432 EREG Epiregulin 10.98 1.98E-07 6.61E-09
Summary of the top 25 genes exhibiting increased mRNA abundance 2 hours post activation, including clone name, accession number, e-value and 
identity of the best BLAST match and average fold change. The P and FDRmax values denote the probability from the moderated t-test and the 
Benjamini and Hochberg false discovery rate values respectively from the analysis of the resting cell values compared to the average activated 
sample values (Pre v Post).
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ual animal values for each gene at 2 hours (data not
shown) and 16 hours (Figure 1B) post activation cluster
together for 9 of the 10 genes. The CCL2 values have the
most spread and one outlying animal influences the dif-
ference between the average microarray and qRT-PCR
results (Figure 1A). However, the results for IL6 cluster
together, illustrating the consistency of the disparity
between qRT-PCR and microarray results for this tran-
script. Investigation of the raw data failed to identify any
obvious reason for the lower fold changes measured by
microarray analysis, in particular the disparity could not
be explained by saturation effects nor excessively low
channel intensities (data not shown).
Discussion
Microarray analysis provides an ideal methodology to
investigate the gene expression profile of thousands of
genes simultaneously, which allows a broader under-
standing of complex events, such as mφ activation and dif-
ferentiation. Here we describe the construction of a
bovine macrophage specific cDNA microarray. The major-
ity of the 5026 clones present on the BoMP microarray
have been selected from a normalized bovine mφ specific
cDNA library [13]. The library was generated from Bos tau-
rus and B. indicus derived monocytes and mφ subjected to
various stimuli, including infection with the protozoan
parasite T. annulata, to maximize the number of tran-
Table 5: The top 25 genes exhibiting decreased mRNA abundance 2 hours post activation.
Clone E value Accession No. Gene Symbol Gene Fold Decrease FDRmax P value
C0006018h16 0.0 NM_031483 ITCH Itchy homolog E3 ubiquitin protein 
ligase
-5.36 2.55E-10 2.79E-12
MARC_2BOV_14N13 e-151 XM_582744 IL16 Interleukin 16 -4.94 9.35E-10 1.41E-11
C0006011p15 0.0 NM_003400 XPO1 Exportin 1 -4.11 3.28E-03 4.70E-04
C0006011d04 e-112 NM_000199 SGSH N-sulfoglucosamine sulfohydrolase -4.05 4.14E-05 2.88E-06
C0005202b11 0.0 NM_006565 CTCF CCCTC-binding factor -3.83 9.04E-06 4.90E-07
C0006014p20 0.0 NM_005642 TAF7 TAF7 RNA polymerase II, TATA 
box binding protein (TBP)-
associated factor, 55kDa
-3.74 7.65E-09 1.61E-10
MARC_1BOV_107K4 0.0 XM_584158 CCR2 Chemokine (C-C motif) receptor 2 -3.70 4.81E-06 2.40E-07
C0005203a5 6.00E-54 NM_032804 C10orf22 Chromosome 10 open reading 
frame 22
-3.69 2.77E-04 2.68E-05
C0006005d04 0.0 XM_588702 UNG Uracil-DNA glycosylase -3.62 4.24E-10 5.00E-12
C0007385D18 0.0 BM087483 - EST -3.60 2.00E-03 2.63E-04
C0006007o03 e-153 NM_016046 EXOSC1 Exosome component 1 -3.51 6.69E-07 2.57E-08
C0006019m08 0.0 XM_868169 - Hypothetical protein LOC616204 -3.51 8.67E-06 4.67E-07
C0005205c2 2.00E-70 NM_024939 RBM35B RNA binding motif protein 35B -3.50 7.22E-08 2.15E-09
C0005207d22 0.0 NM_013444 UBQLN2 Ubiquilin 2 -3.48 1.36E-08 3.13E-10
C0005198j2 7.00E-58 NM_139014 MAPK14 Mitogen-activated protein kinase 
14 (p38)
-3.41 1.36E-08 3.15E-10
C0006005h08 0.0 NM_052911 ESCO1 Establishment of cohesion 1 
homolog 1
-3.36 9.89E-06 5.48E-07
C0005202l16 4.00E-42 XM_545369 C6orf32 Chromosome 6 open reading 
frame 32
-3.32 2.43E-10 2.61E-12
MARC_2BOV_105E23 e-119 NM_153425 TRADD TNFRSF1A-associated via death 
domain
-3.18 3.95E-07 1.45E-08
C0006007o20 e-111 NM_001001806 ZFP36L2 Zinc finger protein 36, C3H type-
like 2
-3.18 3.22E-09 5.75E-11
C0005209h6 e-108 NM_006163 NFE2 Nuclear factor (erythroid-derived 
2), 45kDa
-3.13 3.40E-06 3.27E-07
C0006019p19 e-106 XM_868699 TOB2 Transducer of ERBB2, 2 -3.13 8.37E-07 3.31E-08
C0005202g13 0.0 AV594592 - EST -3.11 7.31E-04 8.25E-05
C0005208j1 0.0 CB221804 - EST -3.10 6.65E-05 5.18E-06
C0006012f10 1.00E-67 NM_145037 FAM55C Family with sequence similarity 55, 
member C
-3.08 1.03E-11 6.98E-14
C0005208h20 0.0 CB420023 - EST -3.01 1.67E-05 9.91E-07
Summary of the top 25 genes exhibiting decreased mRNA abundance 2 hours post activation, including clone name, accession number, e-value and 
identity of the best BLAST match and average fold change. The P and FDRmax values denote the probability from the moderated t-test and the 
Benjamini and Hochberg false discovery rate values respectively from the analysis of the resting cell values compared to the average activated 
sample values (Pre v Post).
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scripts present in the library. A normalized rather than a
subtracted library was generated to ensure that non-mφ
specific genes were represented, as we were interested in
the complete picture of events during host-mφ activation
and not just the subset unique to mφ. Furthermore, the
majority of murine mφ genes exhibiting differential
expression after LPS stimulation were not mφ specific
[10]. Therefore all sequenced clones that matched pub-
lished sequences were included on the BoMP microarray.
The BoMP library also contains a large number of unique
sequences and a proportion of these were also included
on the microarray. Additionally, a further nearly 450
genes were selected for inclusion on the microarray.
Therefore the BoMP microarray is focussed towards inves-
tigating the response of myeloid cells, but is of sufficient
size and diversity to allow for successful normalization of
microarray data.
The BoMP microarray has been validated by investigating
the response of bovine monocytes to IFN-γ and LPS acti-
vation. These compounds are potent, natural activators of
myeloid cells and are frequently used, individually or
together, to experimentally stimulate monocytes
[reviewed in [3]]. A common reference design was used
for this microarray experiment. Because only three time-
points, or treatments, were investigated it would have
been straightforward to use a loop design, which allows
the direct comparison of treatments resulting in higher
statistical power than can be obtained from a common
reference design [21]. However, the experiment described
here forms part of a larger experiment investigating varia-
tion in the response of bovine monocytes derived from
Holstein-Friesians (B. taurus) and Sahiwal (B. indicus) cat-
tle. Therefore a common reference design was used to
allow multifactorial analyses to be carried out looking
Table 6: The top 25 genes exhibiting increased mRNA abundance 16 hours post activation.
Clone E value Accession No. Gene Symbol Gene Fold Increase FDRmax P value
pIL8 0.0 NM_173925 IL8 Interleukin 8 60.09 1.23E-18 4.91E-22
MARC_1BOV_94L3 0.0 NM_174300 CXCL6 Chemokine (C-X-C motif) ligand 6 27.46 1.72E-11 1.23E-13
C0006007m23 2.00E-72 XM_868409 DFNA5 Deafness, autosomal dominant 5 25.42 6.52E-13 2.72E-15
MARC_3BOV_60P17 0.0 NM_174299 CXCL2 Chemokine (C-X-C motif) ligand 2 
(GROβ/MIP2A)
25.14 1.25E-15 1.24E-18
C0006006k10 0.0 XM_586036 ANKRD37 Ankyrin repeat domain 37 23.35 4.05E-07 1.51E-08
C0006016h15 0.0 XM_613370 RGS1 Regulator of G-protein signalling 1 22.10 5.10E-09 1.00E-10
C0006019g12 e-134 CK965770 - EST 21.24 2.26E-11 1.80E-13
C0006019e20 0.0 NM_181015 PRNP Prion protein 20.34 1.05E-20 2.08E-24
C0006014j10 6.00E-96 NM_000214 JAG1 Jagged 1 18.39 1.81E-08 4.42E-10
C0005208m7 e-110 NM_000785 CYP27B1 Cytochrome P450, family 27, 
subfamily B, polypeptide 1
18.39 4.10E-09 7.83E-11
C0006007a22 0.0 NM_022154 SLC39A8 Solute carrier family 39 (zinc 
transporter), member 8
16.01 7.46E-10 1.10E-11
C0005204j16 0.0 XM_864683 CXCL3 Chemokine (C-X-C motif) ligand 3 
(GROγ/MIP2b)
15.28 1.20E-13 3.40E-16
MARC_2BOV_43M14 e-132 NM_001124 ADM Adrenomedullin 14.23 1.20E-13 3.00E-16
C0005198l1 e-138 BI975933 - EST 11.26 2.12E-05 1.30E-06
MARC_3BOV_120N21 e-102 NM_172219 CSF3 Colony stimulating factor 3 
(granulocyte) (G-CSF)
11.14 8.11E-11 7.73E-13
C0006020e20 0.0 CB419326 - EST 10.79 9.10E-12 5.60E-14
MARC_1BOV_103H23 0.0 XM_586821 IL2RB Interleukin 2 receptor, beta 9.96 3.73E-05 2.52E-06
C0006005p10 e-171 NM_001102 ACTN1 Actinin, alpha 1 9.95 7.22E-08 2.14E-09
C0006020m09 e-131 NM_005726 TSFM Ts translation elongation factor, 
mitochondrial
9.63 5.24E-11 4.79E-13
C0006012n18 e-101 NM_000362 TIMP3 TIMP metallopeptidase inhibitor 3 9.50 2.71E-05 1.76E-06
C0005202d9 0.0 XM_870158 ANKRD22 Ankyrin repeat domain 22 9.48 6.36E-17 3.79E-20
pIL1B 0.0 NM_000576 IL1B Interleukin 1, beta 9.37 3.16E-13 1.07E-15
C0006020d11 0.0 XM_865242 ZFAND2A Zinc finger, AN1-type domain 2A 9.28 1.10E-14 1.31E-17
C0005208c5 e-100 NM_002575 SERPINB2 serpin peptidase inhibitor, clade B 
(ovalbumin), member 2
9.25 3.92E-14 6.22E-17
C0005202i8 0.0 XM_583725 APOBEC3A Apolipoprotein B mRNA editing 
enzyme, catalytic polypeptide-like 3A
8.74 1.20E-13 2.97E-16
Summary of the top 25 genes exhibiting increased mRNA abundance 16 hours post activation including clone name, accession number, e-value and 
identity of the best BLAST match and average fold change. The P and FDRmax values denote the probability from the moderated t-test and the 
Benjamini and Hochberg false discovery rate values respectively from the analysis of the resting cell values compared to the average activated 
sample values (Pre v Post).
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across the time course and between cattle breeds. In addi-
tion, the same common reference sample has been used
in a separate microarray experiment investigating the
response of bovine monocytes to T. annulata infection
(Jensen et al., in prep).
There are an increasing number of microarrays available
to investigate bovine gene expression [reviewed by [3]]. A
sub-set of these have been designed to specifically investi-
gate the immune response. The majority of publications
have made use of versions of the bovine total leukocyte
(BoTL) microarray [22]. The latest version, BoTL-5 con-
tains 1391 genes and controls [23]. Other arrays include
the bovine immune-endocrine cDNA microarray contain-
ing amplicons representing 167 genes [24]. Recently a
bovine innate immunity microarray has been described
which contains over 6800 clones [25]. The majority of
these clones have been selected from normalized and sub-
tracted libraries and have not been sequenced. Therefore
there is likely to be considerable redundancy on this
microarray and its full scope is not known.
However, microarray studies investigating the response of
bovine monocytes and mφ to infection and activation
have not made use of these focussed microarrays. The
response of monocytes to Escherichia coli 0157:H7 LPS
was investigated using Incyte Genomics UniGEM V 1.0
human cDNA microarray [4]. Cells were activated for 3
hours and bovine monocyte RNA hybridized with approx-
imately 80% of the gene targets. A total of 44 differentially
expressed genes were identified, 21 of which are repre-
sented on the BoMP microarray. However, only 13 of
these genes exhibited differential expression in the study
reported here, including pentraxin-related gene, rapidly
induced by IL1β (PTX3), CASP8 and FADD-like apoptosis
regulator (CFLAR) and TIMP3. The remaining 8 genes
identified in the earlier study as being differentially
expressed during activation are not exhibiting differential
Table 7: The top 25 genes exhibiting decreased mRNA abundance 16 hours post activation.
Clone E value Accession No. Gene Symbol Gene Fold Decrease FDRmax P value
C0006017i16 0.0 BM088889 - EST -22.29 2.39E-11 1.94E-13
C0005199l3 0.0 BT021551 RNASE4 Ribonuclease, RNase A family, 4 -21.08 1.43E-09 2.33E-11
C0005209g19 - - - Unique singleton -13.17 5.49E-13 2.07E-15
C0005198n19 0.0 NM_000014 A2M Apha-2-macroglobulin -12.22 6.56E-07 2.50E-08
C0006007m24 1.00E-48 NM_174594 RNASE6 Ribonuclease k6 -8.88 9.11E-12 5.79E-14
C0006020f22 0.0 XM_868762 CLEC4A C-type lectin domain family 4, 
member A
-8.45 2.80E-06 1.27E-07
C0005202l16 4.00E-42 XM_545369 C6orf32 Chromosome 6 open reading frame 
32
-8.21 2.43E-10 2.61E-12
BARC_5BOV_46G22 0.0 NM_001037446 CD59 CD59 antigen -8.15 2.11E-07 7.20E-09
C0005206d13 4.00E-57 NM_001009567 MRC1L1 Mannose receptor, C type 1-like 1 -8.15 5.55E-10 7.83E-12
C0005198i18 1.00E-34 AY112657 FGL2 Fibrinogen-like 2 -8.04 5.69E-07 2.16E-08
C0006012b04 0.0 DY139256 - EST -6.79 8.65E-10 1.29E-11
C0005206a23 e-163 CK954547 - EST -6.34 1.27E-06 5.27E-08
C0005920C16 0.0 DN742393 - EST -6.12 7.62E-08 2.29E-09
MARC_3BOV_43C11 e-101 NM_172087 TNFSF13 Tumor necrosis factor (ligand) 
superfamily, member 13 (APRIL)
-5.81 1.51E-08 3.57E-10
C0005201e6 e-100 NM_005923 MAP3K5 Mitogen-activated protein kinase 
kinase kinase 5
-5.65 5.83E-04 6.40E-05
C0006018f03 2.00E-41 DV230110 - EST -5.55 3.13E-06 1.46E-07
C0006005m10 e-121 NM_001031733 CALML4 Calmodulin-like 4 -5.47 2.06E-07 6.98E-09
C0005210k15 0.0 XM_613642 IQGAP2 IQ motif containing GTPase 
activating protein 2
-5.45 1.58E-07 5.13E-09
C0005199n6 0.0 NM_001033990 SCP2 Sterol carrier protein 2 -5.44 3.32E-09 5.99E-11
C0005209n7 7.00E-95 NM_001386 DPYSL2 Dihydropyrimidinase-like 2 -5.16 8.42E-08 2.58E-09
MARC_2BOV_14N13 e-151 XM_582744 IL16 Interleukin 16 -5.12 9.35E-10 1.41E-11
C0006016k03 e-124 XM_607564 FLI1 Friend leukemia virus integration 1 -4.88 1.90E-05 1.14E-06
C0005209m4 0.0 XM_583952 IL6R Interleukin 6 receptor -4.88 2.49E-11 2.08E-13
MARC_2BOV_42H5 0.0 NM_001014945 C1QA Complement component 1, q 
subcomponent, alpha
-4.86 8.14E-06 4.32E-07
C0006018i05 0.0 XM_615814 FKBP5 FK506 binding protein 5 -4.65 7.14E-09 1.46E-10
Summary of the top 25 genes exhibiting decreased mRNA abundance 16 hours post activation, including clone name, accession number, e-value and 
identity of the best BLAST match and average fold change. The P and FDRmax values denote the probability from the moderated t-test and the 
Benjamini and Hochberg false discovery rate values respectively from the analysis of the resting cell values compared to the average activated 
sample values (Pre v Post).
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expression during the time course reported here, e.g.
CASP4 and tumour necrosis factor (TNF-α). These results
could indicate a genuine difference in the response to the
two different stimuli, be due to other technical differences
between the two studies or be due to the failure of the
DNA from the representative clone to hybridize correctly.
The latter is true for TNF-α, the expression of which we
have previously shown to differ during monocyte activa-
tion (data not shown). The failure of this clone has
prompted us to include additional clones representing
TNF-α on the next version of the microarray, which is cur-
rently under construction.
There is a considerable difference in the number of differ-
entially expressed genes identified in LPS stimulated cells
(44 genes) compared to the study reported here (695
genes). The earlier study compared gene expression in LPS
stimulated cells with cells cultured in medium only and
therefore the response of the cells to LPS alone was inves-
tigated [4]. In contrast, the study reported here has inves-
tigated the response of cells to LPS and IFN-γ compared to
resting cells and therefore the cells are also responding to
being in culture conditions for the first time. Furthermore,
our cells were stimulated immediately after isolation,
whilst the previous study used cells that were cultured
overnight before treatment [4].
Bovine derived microarrays have been used to investigate
gene expression in bovine monocytes and mφ in two stud-
ies [[6] &[8]]. The response to alveolar mφ to infection
with virulent and attenuated strains of Mycobacterium bovis
has been investigated using an in house cDNA microarray
[8]. In addition, a commercially available bovine microar-
ray produced by Pyxis Genomics [26] was used to com-
pare gene expression of bovine monocyte-derived mφ
(MDM) infected with M. avium subspecies paratuberculosis
and M. a. avium [6]. This cDNA microarray was con-
structed from bovine spleen and placental cDNA libraries;
however, immunologically important genes are poorly
represented on the microarray. For example, the principal
proinflammatory cytokines, IL1β, IL6 and TNF-α, are not
represented. Therefore the microarray is of limited use
when investigating aspects of the immune system.
Microarray analysis has been used to investigate the
response of human and murine derived mφ to LPS and
IFN-γ [reviewed in [3]]. A total of 219 genes exhibited dif-
ferential expression 6 hours post LPS treatment in the
murine cell line RAW264.7 [27]. Of these 85 (38.8%) are
represented on the BoMP microarray and 42.4% (36) of
these exhibit similar fold changes. The mφ response to a
range of pathogens and PAMPs has been investigated
simultaneously [28,29]. A shared activation program of
expression changes in 191 human mφ genes was found in
response to a range of bacterial pathogens, the majority of
which were also activated by LPS [28]. Ninety-four of
these genes are represented on the BoMP microarray and
64% of up-regulated genes in the activation program were
also up-regulated in the current study, e.g. ninjurin 1
(NINJ1), prostaglandin-endoperoxide synthase 2
Table 8: Details of the qRT-PCR primers and amplicons.
Gene Gene Symbol Clone Direction Sequence (5'-3') Size (bp)
CD9 antigen CD9 BE751736 F TTG GAC TAT GGC TCC GAT TC 261
R CCT TGA TCA CCT CCT CCT TG
CD44 antigen CD44 AJ816969 F TAC CCA CCC ACA AGA GAA CC 102
R AAC CCA TTA CCA GTC ATC CTT G
CD86 antigen CD86 pCD86 F GAA GGT CCC AAG GAT TGG TT 136
R GAT GAG CAG GTC AAA TTG ATG A
Chemokine (C-C motif) ligand 2 CCL2 AJ821161 F TCG CCT GCT GCT ATA CAT TC 274
R AGA GGG CAG TTA GGG AAA GC
Chemokine (C-C motif) receptor 1 CCR1 BE756795 F AAA TGA GAA GAA GGC CAA AGC 140
R TGC TCT GCT CAC ACT TAC GG
Complement component 1, r subcomponent C1R AJ818500 F AGA TTT GTC CGT CTG CCA GT 183
R CCC AGC GGT CAT TTC TCT TA
Fibronectin 1 FN1 AJ819936 F TAT CTT GGT GCC ATT TGC TC 258
R ATC CAC GCT TGT TTC TCT GG
Interleukin 6 IL6 pIL6 F TGA GTG TGA AAG CAG CAA GG 289
R CAG CAG GTC AGT GTT TGT GG
Prion protein PRNP AJ821011 F TGT GTA TGG TGG GAT TGG AA 197
R GCT GGG TCA TCA AAG AAA TG
V-fos FBJ murine osteosarcoma viral oncogene FOS BE755117 F CTT CTC CAG CAT GGG TTC TC 257
R TCT GAG CTC TGC CTC CTG TC
Chromosome 13 open reading frame 8 C13orf8 AJ817183 F AGC AGT GAC CAA GAG CAG GT 205
R TCA TAG CAC GAC AGC AAC AA
F and R denote forward and reverse primers respectively.
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Scatterplots comparing the differential expression measured by qRT-PCR and microarray analysis for 10 investigated genes at 2 time points after act vationFigure 1
Scatterplots comparing the differential expression measured by qRT-PCR and microarray analysis for 10 
investigated genes at 2 time points after activation. A, average log(differential expression). The numbers indicate the 
time post activation. B, log(differential expression) of individual animals at 16 hours post activation. The 10 investigated genes 
were C1R (black circle), CCL2 (red square), CCR1 (green diamond), CD44 (blue triangle), CD86 (orange triangle), CD9 (pink 
triangle), FN1 (purple triangle), FOS (black cross), IL6 (red cross) and PRNP (green star). The dotted lines denote the lines of 
equality (y = x).
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(PTGS2), nuclear factor of kappa light polypeptide gene
enhancer in B-cells inhibitor, alpha (NFKBIA) and jagged
1 (JAG1).
The expression of 10 genes was investigated by qRT-PCR
to validate the microarray results. The same RNA samples
were used for this analysis, rather than the collection of
additional samples, because the principal aim was to con-
firm to results obtained from the microarray experiment
rather than to investigate the expression of particular
genes. Overall there was good correlation between the
microarray and qRT-PCR results, with a correlation value
of 0.78. This level of correlation is comparable to that seen
in a large scale validation study of over 1300 genes
recently reported [30]. However, the dominant pattern
observed in the comparison of microarray and qRT-PCR
results reported here closely follows the line of equality,
which was not observed in the large scale study [30]. The
average logarithms of differential expression for the two
time points were remarkably similar for 6 of the 10 genes.
The qRT-PCR analysis was more sensitive for the remain-
ing 4 genes and detected increased differential expression
over the microarray analysis, particularly for IL6, which
was underestimated by as much as 100 fold. There are sev-
eral possible explanations for the disparity between these
methodologies, including; fluorescence saturation and
specificity. However, analysis has confirmed that the dis-
parity in IL6 results is not caused by the saturation of the
fluorescence on the microarray (data not shown). Closely
related gene-family members, sharing more than 80%
sequence homology, can cross-hybridize in cDNA micro-
array experiments resulting in false positive results [31].
However, this can not explain the results for IL6, which is
not part of a closely related gene family and the hybridi-
zation signals were lower than expected. The most proba-
ble cause of the disparity in IL6 results is sub-optimal
hybridization of IL6 on the microarray. In contrast, the
qRT-PCR amplification is optimized on a gene basis.
Due to the limited amount of totRNA generated from the
peripheral monocytes, the microarray experiment was car-
ried out using aRNA. The suitability of this approach has
been validated by previous studies [32]. The qRT-PCR was
carried out on the original totRNA samples used to gener-
ate the aRNA used in the microarray experiment. The sim-
ilarity between the majority of the results supports the use
of aRNA for microarray analysis. However, variable ampli-
fication of transcripts may account for the disparity
between the qRT-PCR and microarray results for IL6. This
could be investigated by repeating the qRT-PCR analysis
using the aRNA samples. Unfortunately, this was not pos-
sible due to limited amounts of the samples remaining.
The log(fold changes) were encouragingly consistent
between animals for all but one of the genes examined. A
comparison of the results of statistical significance tests
for the two methodologies has not been attempted. The
microarray results would require recalculating for a fair
comparison, as they are penalized for the multiple testing
of over 5000 genes and also have the residual variances for
each gene "shrunk" towards the median residual variance
to improve the false discovery rate for the list of top genes
exhibiting differential expression.
Further investigation of the validity of the microarray
results concentrated on the top gene lists (Tables 4, 5, 6,
7), by in silico analysis, searching the literature for corrob-
orative data. Unfortunately, corroborative data has not
been found for a proportion of the genes. Several of the
most differentially expressed genes currently only match
ESTs or are unique to the BoMP library. Exploration of
these may provide insights into novel pathways involved
in the reprogramming of the innate immune cell after
infection or inflammation. Further work on the bovine
genome sequencing project should provide more infor-
mation on these sequences in the future.
Results for two of the top differentially expressed genes are
inconsistent with previously published data. Dihydropyri-
midinase-like 2 (DPYSL2) is down-regulated over 5 fold
in this study. However, expression of the gene has been
reported as up-regulated upon monocyte activation [33].
Similarly, previous studies have shown that C1Q is up-
regulated during LPS and IFN-γ stimulation [34]. In the
current study both C1QA and C1QB are down-regulated
4.8 fold and 2.9 fold respectively. The disparity between
the results may result from differences in experimental
design, cell types or species differences, or from other
technical differences between the studies.
Many of the top differentially expressed genes have been
shown to be differentially expressed in activated myeloid
cells by previously microarray analysis. Sixteen of the
genes were listed in the mφ activation program, including;
N-sulfoglucosamine sulfohydrolase, adrenomedullin and
ribonuclease k6 [28]. Similarly seven of the top genes
were also described in the study of gene expression in
RAW264.7 cells, e.g. exportin 1 [27] and three of the top
genes were differentially expressed in the only other pub-
lished paper on bovine monocyte gene expression, e.g.
TNF-α induced protein 3 (TNFAIP3) [4].
The biological function of prion protein is still unclear,
although mRNA and protein levels increase upon activa-
tion of many leukocytes, including T lymphocytes [35].
Mφ from prion protein knockout mice show lower rates of
phagocytosis and recruit a different subset of leukocytes,
suggesting that the protein plays an important role in mφ
function [36]. Differentiation of monocytes to dendritic
cells (DC) increases surface expression of prion protein
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[37] and IFN-γ stimulation triggers increased prion pro-
tein expression in CD14+ peripheral cells [35].
Exposure to IFN-γ also induces phorbol-12-myristate-13-
acetate-induced protein 1 (PMAIP1) expression, which
disrupts the mitochondrial outer membrane integrity and
is involved in apoptosis [38]. Apolipoprotein B mRNA
editing enzyme, catalytic polypeptide-like 3A
(APOBEC3A) acts to inhibit retroviral replication and
expression of the closely related proteins APOBEC3B and
APOBEC3C are stimulated by IFN-γ [39].
An additional 13 genes from the top differentially
expressed genes have been shown to be differentially
expressed in myeloid cells after LPS treatment. These
include up-regulation of IL2RB [40] and down-regulation
of IL6R [41], CCR2 [42] and CD59 [43]. Similarly, the
nuclear receptor subfamily 4, group A, member 3
(NR4A3), which is mediated by NF-κB signalling is up-
regulated in RAW264.7 stimulated with LPS [44]. Further-
more, the zinc transporter solute carrier family 39 mem-
ber 8 (SLC39A8) is expressed at very low levels in
unstimulated monocytes, but levels increase after LPS
stimulation [45].
The information described in this report, particularly the
expression changes in unique or unknown genes, may in
the future suggest new candidates for disease resistance
genes. Furthermore, the results may suggest new ways to
effectively stimulate the innate immune system, leading
to improvements in the design of vaccines and adjuvants.
Conclusion
Here we report the construction of a 5 K bovine macro-
phage specific cDNA microarray, which has been vali-
dated by investigating the response of bovine monocytes
to culturing and stimulation with IFN-γ and LPS. Over
690 differentially expressed genes were identified and the
results for a selection of these genes have been confirmed
by qRT-PCR analysis. Therefore the BoMP microarray is a
useful resource for investigating gene expression in bovine
myeloid cells. A second version of the microarray is cur-
rently under construction, which contains an additional
500 clones to improve the representation of various bio-
logical pathways on the microarray. Both versions of the
BoMP microarray will be publicly available through the
ARK-Genomics Centre for Functional Genomics in Farm
Animals [18].
Methods
Construction of the BoMP microarray
Clone selection
5026 sequence elements have been chosen for inclusion
on the BoMP microarray, see Additional file 1 for a com-
plete annotated list. These have been derived from a
number of resources (Table 1). The majority of the clones
(4585 clones) were derived from the normalized BoMP
cDNA library [13], generated from RNA samples collected
from B. taurus and B. indicus derived cells subjected to var-
ious stimuli. A further 381 clones were selected from the
MARC 1–4 BOV libraries and others available at the ARK-
Genomics facility [16,17]. In addition, 60 amplicons were
generated to represent immunologically important genes
that were not available in the libraries at our disposal, e.g.
IL6 and IL8.
Generation of amplicons
Sixty immunologically important genes were selected for
amplicon generation (Table 2). Oligonucleotides were
designed for the 60 genes using the Primer3 website
[46,47]. First strand cDNA was reverse transcribed from
0.5 µg myeloid cell totRNA using oligo(dT) primer and
Superscript II (Invitrogen) according to the manufac-
turer's instructions. Two microlitres of the cDNA was
amplified using the gene specific primers in a 100 µl
polymerase chain reaction (PCR) containing the follow-
ing; 1 × PCR buffer, 1.5 mM MgCl2, 200 µM dNTP mix,
200 nM forward and reverse primers and 0.5 units Taq
polymerase (ABgene). PCR amplification was carried out
using the following cycle profile: one cycle of 95°C for 3
minutes, 60°C for 30 seconds and 72°C for 45 seconds,
followed by 39 cycles of 95°C for 30 seconds, 60°C for 30
seconds and 72°C for 45 seconds. The final cycle had an
extension at 72°C for 5 minutes. The PCR products were
purified using QIAquick Gel Extraction Kit (Qiagen)
before being cloned into pGEM-T easy vector (Promega)
according to the manufacturer's instructions. The result-
ing plasmids were sequenced to ensure amplification of
the specific product (data not shown).
Microarray construction
The BoMP microarray was constructed from the 5026
clones described above and additional controls, includ-
ing; chicken and bovine genomic DNA, calf thymus DNA,
salmon sperm DNA, glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH), γ-actin, landing lights, spotting
buffer and the Alien SpotReports 1–10 (Stratagene). The
controls are distributed evenly across the microarray. The
plasmid DNA was purified using MagAttract 96 Miniprep
chemistry on a Biorobot 8000 platform (Qiagen). The
cDNA inserts were PCR amplified using the oligonucle-
otides CGATTAAGTTGGGTAACGC and CAATT-
TCACACAGGAAACAG in 50 µl reactions using 1 µl
plasmid template. Amplified DNA was purified by Multi-
screen 384 well PCR purification plates (Millipore) on a
Multiprobe II liquid handling platform (Perkin Elmer).
The presence of products was confirmed by agarose gel
electrophoresis and quantified by Picogreen assay (Molec-
ular Probes) on a Flouroskan Ascent flourescent plate
reader (Thermo Life Science).
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DNA was resuspended to 150 ng/µl in spot buffer (150
mM sodium phosphate, 0.01% sodium dodecyl sulphate)
before being spotted in duplicate on to amino-silane
coated GAPSII slides (Corning) using a Biorobotics Micro-
Grid II spotter (Genomic Solutions). The microarray is
laid out in a 12 × 4 grid, where each block corresponds to
one of 48 print tips. Each block comprises a 16 × 15 grid
of spots.
Printed microarray slides were treated using succinic
anhydride and 1-methyl-2-pyrrolidinone (Sigma) to
block unbound amino groups, followed by a wash in
95°C MilliQ water before hybridization.
Sample collection
Peripheral blood was isolated from 6 Holstein-Friesian
(B. taurus) cattle maintained at the Roslin Institute, UK.
These animals, 2 females and 4 males, were between 1–3
years of age and kept on pasture. The blood was collected
aseptically into acid citrate dextrose and immediately
stored on ice. Under cold conditions peripheral blood
mononuclear cells (PBMC) were separated by density gra-
dient centrifugation on Lymphoprep (Axis-Shield),
washed three times with phosphate buffered saline (PBS)
and resuspended at 107 cells/ml in PBS supplemented
with 1% foetal bovine serum (FBS). Peripheral monocytes
were isolated from PBMC by positive selection using a
predetermined optimum concentration of the mono-
clonal antibody IL-A24, which recognizes signal-regula-
tory protein alpha (SIRPA) [48], and the MACS system
according to the manufacturer's instructions (Miltenyi
Biotec). FACS analysis confirmed that the cell purity
exceeded 95% (data not shown).
The purified monocytes from each animal were resus-
pended at 107cells/ml in RPMI-1640 medium supple-
mented with 10% FBS, 20 ng/ml LPS derived from E. coli
serotype 055:B5 (Sigma) and 300 U/ml recombinant
ovine IFN-γ, kindly supplied by Dr. G. Entrican (Moredun
Research Institute). Cells from each animal were divided
into 3 aliquots and incubated at 37°C in a 5% CO2 incu-
bator. The cells were harvested at 0, 2, and 16 hours post
activation. The activated monocytes were pelleted,
washed with PBS and stored in RNAlater (Ambion) at 4°C
before RNA extraction.
RNA preparation
totRNA was extracted from the 18 cell samples using the
RNeasy mini kit (Qiagen) according to the manufacturer's
instructions. The quality and quantity of the resulting
RNA was determined by gel electrophoresis, spectropho-
tometry at 260 nm and 280 nm and by Agilent 2100 Bio-
analyzer. Linearly amplified aRNA was generated from 0.5
µg totRNA using the MessageAmp aRNA kit (Ambion)
according to the manufacturer's instructions and incorpo-
rating modified 5-(3-aminoallyl)-UTP. All totRNA sam-
ples underwent a single round of amplification. The
quality and the quantity of the resulting aRNA was ana-
lysed by spectrophotometry and Agilent 2100 Bioana-
lyzer.
RNA labelling & hybridizations
Fluorescent cyanine (Cy) dyes, either Cy3 or Cy5 as
appropriate, were indirectly incorporated into each 1.2 µg
aRNA sample by coupling to the modified UTP using the
protocol described on the ARK-Genomics website [18].
The labelled aRNA was purified using a DyeEx spin col-
umn (Qiagen) and the labelling efficiency was deter-
mined by running 0.5 µl of each sample on a 1% agarose
gel.
Hybridizations were carried out in a GeneTac automated
hybridization station (Genomic Solutions). The Cy3 and
Cy5 labelled aRNA were mixed and added to 125 µl
hybridization solution (ARK-Genomics protocols [18])
and hybridized onto the BoMP microarray for 12 hours.
The microarray slides were then washed in wash buffers of
increasing stringency (Genomic Solutions). After removal
from the hybridization station the microarray slides were
sequentially washed in post wash buffer and isopropanol
for one minute before being dried by centrifugation at 220
g for 6 minutes. The dried slides were scanned in a Scanar-
ray 5000 XL scanner (GSI Lumonics) at constant laser
power of 80% and 78% for Cy3 and Cy5 respectively.
Experimental design
The experiment described here was part of a larger micro-
array experiment of 36 microarray slides comparing the
response of monocytes derived from 6 Holstein-Friesian
(B. taurus) and 5 Sahiwal (B. indicus) cattle to stimulation
with IFN-γ and LPS, which will be described elsewhere
(Jensen et al., in prep). The RNA samples from each ani-
mal and time point were analyzed separately. The result-
ing aRNA from each sample was hybridized in
competition with a pooled reference sample, made up of
5 resting monocyte aRNA samples; 3 Sahiwal and 2 Hol-
stein samples. A common reference design was used to
simplify the multifactorial analysis of the complete exper-
iment. The reference sample was labelled with Cy3 and
the treatment sample with Cy5 on each microarray slide.
The microarray data has been submitted to ArrayExpress
and assigned the accession number E-MAXD-16 [19,20].
Microarray data analysis
Microarray spot intensity and quality data were extracted
from the scanned images using the BlueFuse software ver-
sion II (BlueGnome). Each slide was normalized sepa-
rately, using the log2-ratios of treatment to reference
intensities for all the non-control spots. Normalization
and analysis was based on the Limma package of Biocon-
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ductor [49], with additional plotting from the Bioconduc-
tor Marray package. However, the Limma models were
modified at both the normalization and analysis stages.
The normalization was a 2-step process of spatial then
intensity dependent bias correction. The spatial bias cor-
rection was carried out separately for each 2 × 2 group of
blocks, by subtracting corresponding row and column
means (RC correction, excluding control spots) from each
data spot. This simple correction has been used in crop
experiments to remove spatial trends and has also been
suggested for similar trends across microarrays [50]. The
rows and columns may stretch across the whole slide (glo-
bal) or only across the spots within a block, to more
strongly reflect local spatial patterns. The choice of 2 × 2
groups of blocks results in a smoothing of the spatial pat-
tern intermediate between these two. The intensity
dependent bias was removed by local block-lowess [51].
The choice of level, global or local, for the two normaliza-
tion steps was informed by examination of spatial heat
diagrams and M-A plots for all possible normalization
combinations (Figure 2).
The time course effects of the log ratios of treatment to ref-
erence for means of replicate spots on each microarray
slide were analyzed by regression models, which allowed
for repeated observations from each animal. The Limma
eBayes correction [52] was used to shrink the residual var-
iances of genes towards their approximate median value.
The effect of time was assessed by two comparisons;
firstly, the values from resting samples were compared to
activated sample values (at both 2 or 16 hours). Secondly,
the 2 hour values were compared to the 16 hour values.
Comparisons were made using Smyth's moderated t-test
[52]. FDRmax values for each contrast were calculated
using the method of Benjamini and Hochberg [53], the
default multiple testing method in Limma. Genes with
FDRmax values less than or equal to 0.01 were considered
as significantly different. To refine the list of differentially
expressed genes further to those of probable biological
relevance, only those genes exhibiting a 2 fold or greater
average change at 2 hours or 16 hours post activation
compared to resting cells were considered.
Validation of microarray results
Quantitative RT-PCR was carried out on 10 genes to verify
the microarray results. Oligonucleotides were designed
for each gene using Primer3 [46,47] and Netprimer (Bio-
soft International) software [54] (Table 8). The qRT-PCR
analysis was carried out on the same totRNA samples
from Holstein-derived monocytes used to generate aRNA
for the microarray experiment. First strand cDNA was
reverse transcribed from 0.5 µg totRNA using oligo(dT)
primer and Superscript II (Invitrogen) according to the
manufacturer's instructions. The resulting cDNA was
diluted 1:50 for all genes except FOS, when the cDNA was
diluted 1:10. FOS was down-regulated during activation
and therefore a more concentrated cDNA sample was
required for successful qRT-PCR amplification of FOS in
the 16 hour time points.
The mRNA levels of each transcript were quantified by
PCR using the Platinum SYBR Green qPCR Supermix
UDG kit (Invitrogen). Reactions were carried out in 20 µl
volumes containing; 1 × supermix (Sybr Green, Platinum
taq DNA polymerase, dNTPs, UDG and stabilizers), 0.4 µl
Rox dye, 1 µl forward and reverse primers at predeter-
mined optimal concentrations and 5 µl diluted cDNA.
Amplification and detection of products was carried out
using a Mx3000P PCR machine (Stratagene) with the fol-
lowing cycle profile: 50°C for 2 minutes, 95°C for 2 min-
utes followed by 40 cycles of 95°C for 15 seconds and
60°C for 30 seconds. The detection of a single product
was verified by dissociation curve analysis. Each PCR
experiment was carried out in triplicate and contained
several non-template controls and a log10 dilution series
of the representative clone from the array or activated
monocyte RNA. The relative quantities of mRNA were cal-
culated using the method described by Pfaffl [55]. The
qRT-PCR results for Chromosome 13 open reading frame
8 (C13orf8) [EMBL: AJ817183] were used to calculate dif-
ferences in the template RNA levels and thereby standard-
ize the results for the genes of interest. C13orf8 was
selected from microarray and qRT-PCR analyses as a con-
stitutively and moderately expressed gene in activated, T.
annulata-infected and resting Holstein and Sahiwal
derived monocytes (data not shown). Where Pfaffl [55]
uses ratios of the control gene to target gene values, we use
the differences between the corresponding logarithms of
these values. The qRT-PCR values are then comparable
with the log(intensity ratios) from the microarray analy-
sis, both in scale and as estimates of the log(geometric
mean) values.
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Representative spatial heat maps and M-A plots of raw and normalized dataFigure 2
Representative spatial heat maps and M-A plots of raw and normalized data. A, spatial heat map for a representa-
tive microarray slide before and after normalization. The footnote gives the range of M values for the slide (z-range) and the 
range excluding the extreme 5% tails of the distribution of M values (saturation) which are excluded from the plot. B, M-A 
plots for the same representative microarray slide before and after normalization. Green spots denote control genes and the 
coloured lines represent the curve for each print tip.
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